EXHIBIT 7(1) AGREEMENT WITH RESPECT TO SCHEDULE 13D The undersigned hereby agree that any Statement on Schedule 13D to be filed with the Securities and Exchange Commission by any of the undersigned, including any amendment thereto, with respect to...Bay City Capital Management LLC • September 3rd, 1997 • In vitro & in vivo diagnostic substances
The undersigned hereby agree that any Statement on Schedule 13D to be filed with the Securities and Exchange Commission by any of the undersigned, including any amendment thereto, with respect to securities of NeoRx Corporation, a Washington corporation, may be filed by Bay City Capital Management LLC on behalf of each of the undersigned.
